(Q35082553)

6 August 2017

title

Outcomes among HIV-1 infected individuals first starting antiretroviral therapy with concurrent active TB or other AIDS-defining disease (English)

1 reference

6 August 2017

7

Beatriz Grinsztejn

1 reference

Nagalingeswaran Kumarasamy

6 August 2017

12

object named as

Nagalingeswaran Kumarasamy

1 reference

6 August 2017

15

Thomas B Campbell

1 reference

6 August 2017

14

Timothy Flanigan

1 reference

6 August 2017

10

James Hakim

1 reference

6 August 2017

11

Mulinda Nyirenda

1 reference

6 August 2017

2

Laura Smeaton

1 reference

6 August 2017

13

Umesh G Lalloo

1 reference

6 August 2017

6

Apsara Nair

1 reference

6 August 2017

5

Ann Walawander

1 reference

6 August 2017

9

Cecilia Kanyama

1 reference

6 August 2017

André R S Périssé

1

1 reference

6 August 2017

Yun Chen

3

1 reference

6 August 2017

Alberto La Rosa

4

1 reference

6 August 2017

Breno Santos

8

1 reference

6 August 2017

Michael D Hughes

16

1 reference

6 August 2017

P E A R L S study team of the ACTG

17

1 reference

6 August 2017

language of work or name

English

0 references

publication date

31 December 2013

1 reference

6 August 2017

1 reference

6 August 2017

volume

8

1 reference

6 August 2017

issue

12

1 reference

6 August 2017

page(s)

e83643

1 reference

Creative Commons Attribution 4.0 International

6 August 2017

copyright license

start time

31 December 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Efficacy and safety of three antiretroviral regimens for initial treatment of HIV-1: a randomized clinical trial in diverse multinational settings

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877069

Prevalent tuberculosis and mortality among HAART initiators

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877069

Rate and determinants of treatment response to different antiretroviral combination strategies in subjects presenting at HIV-1 diagnosis with advanced disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877069

Very late initiation of HAART impairs treatment response at 48 and 96 weeks: results from a meta-analysis of randomized clinical trials.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877069

Timing of antiretroviral therapy for HIV-1 infection and tuberculosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877069

Antiretroviral therapy in prevention of HIV and TB: update on current research efforts

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877069

The effect of tuberculosis on mortality in HIV positive people: a meta-analysis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877069

Optimum time to start antiretroviral therapy during HIV-associated opportunistic infections

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877069

Timing of initiation of antiretroviral drugs during tuberculosis therapy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877069

Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877069

Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877069

Failure to reconstitute CD4+ T-cells despite suppression of HIV replication under HAART.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877069

The survival benefits of AIDS treatment in the United States

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877069

The prevalence and risk of immune restoration disease in HIV-infected patients treated with highly active antiretroviral therapy.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877069

Immune restoration disease after antiretroviral therapy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877069

Decline in the AIDS and death rates in the EuroSIDA study: an observational study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877069

The growing burden of tuberculosis: global trends and interactions with the HIV epidemic

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877069

The changing clinical epidemiology of AIDS in the highly active antiretroviral therapy era

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3877069

Response to HAART in Treatment-Naive HIV-Infected Patients with a Prior Diagnosis of Tuberculosis or other Opportunistic Infections

8 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0083643

Survival rate and risk factors of mortality among HIV/tuberculosis-coinfected patients with and without antiretroviral therapy

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24391801

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Effect of simultaneous use of highly active antiretroviral therapy on survival of HIV patients with tuberculosis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24391801

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1371/JOURNAL.PONE.0083643

1 reference

6 August 2017

0 references

1 reference

6 August 2017

1 reference